gms | German Medical Science

GMS Current Posters in Otorhinolaryngology - Head and Neck Surgery

German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNOKHC)

ISSN 1865-1038

Endoscopic management of juvenile nasopharyngeal angiofibroma: our experience


  • corresponding author Georgios Fyrmpas - AHEPA Hospital, Thessaloniki, Greece
  • Iordanis Konstantinidis - Papageorgiou Hospital, Thessaloniki, Greece
  • Athanassia Printza - Papageorgiou Hospital, Thessaloniki, Greece
  • Jiannis Constantinidis - AHEPA Hospital, Thessaloniki, Greece

GMS Curr Posters Otorhinolaryngol Head Neck Surg 2010;6:Doc79

doi: 10.3205/cpo000572, urn:nbn:de:0183-cpo0005726

Published: April 22, 2010

© 2010 Fyrmpas et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.



Introduction: The endoscopic resection of juvenile nasopharyngeal angiofibroma (JNA) emerges as an alternative approach to open surgical procedures due to reduced morbidity and comparable recurrence rates. The purpose of this study is to present our experience with the endoscopic management of JNA.

Patients/methods: Retrospective chart review of six male patients with mean age 14.6 years (range 10–21) who were treated endoscopically for JNA at our institution between the years 2003–2009. Two tumours were classified as stage I and 4 tumours as stage II according to the Fisch staging system. Three patients underwent preoperative embolisation. The endoscopic treatment involved posterior ethmoidectomy, middle meatal antrostomy, sphenoidotomy, clipping of the sphenopalatine artery and its branches and drilling of the pterygoid basis. All patients underwent magnetic resonance imaging 3 months post operatively and then at yearly follow up.

Results: Mean follow up was 34 months (range 12–62). All but one patient were free of macroscopic disease. A patient with stage II JNA developed recurrence after 9 months. The residual tumour was resected endoscopically and the sphenopalatine foramen widened by drilling. The patient is free of disease 17 months postoperatively. The intra-operative blood loss was acceptable (450–800 ml, mean: 560ml) and no patient required a blood transfusion. Patients were discharged after 4 to 8 days (mean 5 days). No complications were reported.

Conclusions: Our results are in line with those of other investigators regarding the endoscopic management of stage I and II JNA. The endoscopic approach is a safe and effective treatment modality for JNA due to the lack of external scars, minimal bone resection and enhanced visualization of the tumour extent.